Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs61733126 | chr16:71712786 | A/G | 8.79E-6 | 175 | 24.23 | 31.48 | 14.5 | KM Plot |
PCPG | rs61733750 | chr17:1417231 | A/C | 1.23E-5 | 177 | 25.05 | 25.87 | 13.02 | KM Plot |
PCPG | rs61742149 | chr2:24290671 | G/A | 6.56E-5 | 176 | 24.62 | 35.23 | 21.77 | KM Plot |
PCPG | rs61753396 | chr7:1105372 | A/G | 0.000262 | 173 | 25.87 | 24.95 | 49.58 | KM Plot |
PCPG | rs61774839 | chr1:56336609 | G/A | 2.0E-7 | 174 | 25.53 | 25.77 | 13.27 | KM Plot |
PCPG | rs61779697 | chr1:40499879 | C/T | 3.09E-6 | 172 | 24.85 | 24.88 | 37.18 | KM Plot |
PCPG | rs61781896 | chr1:40518166 | G/A | 0.000336 | 175 | 25 | 27.27 | 25.17 | KM Plot |
PCPG | rs61781897 | chr1:40518490 | C/T | 0.000336 | 174 | 25.2 | 27.27 | 25.17 | KM Plot |
PCPG | rs61781906 | chr1:40520607 | C/T | 6.64E-7 | 174 | 25.2 | 26.92 | 24.7 | KM Plot |
PCPG | rs61833466 | chr1:244153677 | C/T | 0.000344 | 171 | 27.47 | 22.15 | 15.8 | KM Plot |
PCPG | rs61833472 | chr1:244159220 | G/A | 0.000285 | 175 | 27.47 | 20.17 | 15.8 | KM Plot |
PCPG | rs61852569 | chr10:90736014 | G/A | 6.01E-5 | 171 | 25.53 | 24.7 | 2.93 | KM Plot |
PCPG | rs61874403 | chr10:131949879 | T/C | 0 | 177 | 25.47 | 24.47 | 3.17 | KM Plot |
PCPG | rs61876573 | chr10:131544084 | C/T | 6.91E-6 | 175 | 25.17 | 28.35 | 14.25 | KM Plot |
PCPG | rs61876575 | chr10:131548027 | A/C | 6.75E-6 | 176 | 25.08 | 28.35 | 14.25 | KM Plot |